Abbott Laboratories (ABT) Financials

ABT Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 73.2 billion 34.4 billion
2023-09-30 72.1 billion 34.4 billion
2023-06-30 73.4 billion 36.0 billion
2023-03-31 73.8 billion 36.6 billion

ABT Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 2.3 billion 114.0 million
2023-09-30 1.3 billion 117.0 million
2023-06-30 696.0 million 132.0 million
2023-03-31 763.0 million 281.0 million

ABT Net Income

Graph available only for supporters. Become a supporter to see it.
DateNet Income
2023-12-31 1.6 billion
2023-09-30 1.4 billion
2023-06-30 1.4 billion
2023-03-31 1.3 billion

ABT Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 7.3 billion - 949.0 million
2023-09-30 7.0 billion 14.5 billion -
2023-06-30 8.2 billion 14.6 billion -
2023-03-31 10.2 billion 14.6 billion -

ABT Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 1.7 billion
2023-09-30 1.7 billion
2023-06-30 1.8 billion
2023-03-31 1.8 billion

ABT Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 755.0 million 690.0 million 2.7 billion -
2023-09-30 560.0 million 672.0 million 2.7 billion -
2023-06-30 507.0 million 715.0 million 2.7 billion -
2023-03-31 380.0 million 654.0 million 2.8 billion -

ABT Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 10.2 billion 5.0 billion
2023-09-30 10.1 billion 4.6 billion
2023-06-30 10.0 billion 4.5 billion
2023-03-31 9.7 billion 4.3 billion

ABT

List: Contenders

Price: 113.66USD

52 week price:
89.24
120.96

Dividend Yield: 1.85%

5-year range yield:
1.34%
2.08%

Forward Dividend Yield: 1.94%

Payout Ratio: 67.48%

Payout Ratio Range:
22.30%
245.60%

Dividend Per Share: 2.20 USD

Earnings Per Share: 3.26 USD

P/E Ratio: 34.97

Exchange: NYQ

Sector: Healthcare

Industry: Medical Devices

Volume: 5.1 million

Ebitda: 1.7 billion

Market Capitalization: 205.8 billion

Average Dividend Frequency: 4

Years Paying Dividends: 42

DGR3: 10.70%

DGR5: 11.14%

DGR10: 11.53%

DGR20: 7.48%

Links: